Cyclovirobuxine Prevents Osteoclastogenesis and Estrogen Deficiency-Induced Bone Loss by Inhibiting ROS Generation via the PI3K/AKT/FOXO1 Pathway
Journal of Agricultural and Food Chemistry · 2026
DOI: 10.1021/acs.jafc.6c01670 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, 2026. Verfasst von Qiufei Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Regenerative Medicine, Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and App…. Hauptthemen laut MEDLINE: Forkhead Box Protein O1, Osteoclasts, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases. Die Arbeit nennt 79 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Innovation Project of Guangxi Graduate Education.
Abstract (Originalsprache)
This research investigates how CVB modulates osteoclast development and functional activity, and elucidates its underlying molecular mechanisms. Osteoclasts are pivotal mediators of bone matrix degradation and reconstruction, and their overactivation is an important mechanism in diseases such as osteoporosis. By extracting bone marrow-derived macrophages (BMMs) from mouse bone marrow and inducing them to differentiate into osteoclasts under RANKL and M-CSF stimulation, we found that CVB dose-dependently inhibited osteoclast differentiation, pseudopod structure formation, acid secretion and bone resorption function at nontoxic concentrations; inhibited PI3K/AKT pathway activation, enhanced the nuclear translocation and expression of FOXO1, and upregulated antioxidant enzymes such as CAT and SOD1, thereby suppressing intracellular ROS accumulation. Animal experiments further demonstrated that CVB exerted a protective effect against skeletal degradation in ovariectomized mice. These results suggest that CVB suppresses osteoclastogenesis and their resorptive function through modulation of MAPK and PI3K/AKT/FOXO1 pathways and by enhancing antioxidant defense, which has potential therapeutic value for antiosteoporosis treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi Key Laboratory of Regenerative Medicine, Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-Constructed by the Province and Ministry, Guangxi Medical…
- Guigang City People's Hospital, The Eighth Affiliated Hospital of Guangxi Medical University, Guigang, Guangxi537100, China.
- Research Centre for Regenerative Medicine, Department of Orthopedics Trauma and Hand Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi530021, China.
- Key Laboratory of Metabolism and Health, School of Basic Medical Sciences, Henan University, Kaifeng, Henan475000, China.
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Guangxi Medical University, Nanning, Guangxi530021, China.
- School of Biomedical Sciences, The University of Western Australia, Perth, Western Australia6009, Australia.
ORCID-Profile: Qiufei Li
Förderung
- National Natural Science Foundation of China
- Innovation Project of Guangxi Graduate Education
Zitieren
APA
Li, Q., Hai, N., Liao, J., Teng, H., Chen, L., Hu, Z., Sun, R., Yang, B., Zhao, J., Xu, J., Liu, Q., & Zhou, B. (2026). Cyclovirobuxine Prevents Osteoclastogenesis and Estrogen Deficiency-Induced Bone Loss by Inhibiting ROS Generation via the PI3K/AKT/FOXO1 Pathway. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.6c01670
Vancouver
Li Q, Hai N, Liao J, Teng H, Chen L, Hu Z, et al. Cyclovirobuxine Prevents Osteoclastogenesis and Estrogen Deficiency-Induced Bone Loss by Inhibiting ROS Generation via the PI3K/AKT/FOXO1 Pathway. Journal of Agricultural and Food Chemistry. 2026. doi:10.1021/acs.jafc.6c01670
BibTeX
@article{Li2026,
author = {Li, Qiufei and Hai, Na and Liao, Jindeng and Teng, Hailong and Chen, Linlin and Hu, Zutuan and Sun, Ran and Yang, Biao and Zhao, Jinmin and Xu, Jiake and Liu, Qian and Zhou, Bo},
title = {Cyclovirobuxine Prevents Osteoclastogenesis and Estrogen Deficiency-Induced Bone Loss by Inhibiting ROS Generation via the PI3K/AKT/FOXO1 Pathway},
journal = {Journal of Agricultural and Food Chemistry},
year = {2026},
doi = {10.1021/acs.jafc.6c01670}
}
EUVIMED